EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Development of a Minimum Dataset for the Monitoring of Recombinant Human Growth Hormone Therapy in Children with Growth Hormone Deficiency: A GloBE-Reg Initiative

Suet Ching Chen, Jillian Bryce, Minglu Chen, Evangelia Charmandari, Jin-Ho Choi, Xinyu Dou, Chunxiu Gong, Rasha Hamza, Jamie Harvey, Andrew R Hoffman, Reiko Horikawa, Gudmundur Johannson und 8 weitere

Hormone Research in Paediatrics · 2024

DOI: 10.1159/000533763 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Hormone Research in Paediatrics, 2024. Verfasst von Suet Ching Chen und 19 weiteren Autor:innen. Beteiligte Einrichtung: Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children, Glasgow, UK. Hauptthemen laut MEDLINE: Human Growth Hormone, Recombinant Proteins. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Although there are some recommendations in the literature on the assessments that should be performed in children on recombinant human growth hormone (rhGH) therapy, the level of consensus on these measurements is not clear. The objective of the current study was to identify the minimum dataset (MDS) that could be measured in a routine clinical setting across the world, aiming to minimise burden on clinicians and improve quality of data collection.

Methods

This study was undertaken by the growth hormone (GH) scientific study group in GloBE-Reg, a new project that has developed a common registry platform that can support long-term safety and effectiveness studies of drugs. Twelve clinical experts from 7 international endocrine organisations identified by the GloBE-Reg Steering Committee, 2 patient representatives, and representatives from 2 pharmaceutical companies with previous GH registry expertise collaborated to develop this recommendation. A comprehensive list of data fields routinely collected by each of the clinical and industry experts for children with growth hormone deficiency (GHD) was compiled. Each member was asked to determine the: (1) importance of the data field and (2) ease of data collection. Data fields that achieved 70% consensus in terms of importance qualified for the MDS, provided <50% deemed the item difficult to collect.

Results

A total of 246 items were compiled and 27 were removed due to redundancies, with 219 items subjected to the grading system. Of the 219 items, 111 achieved at least 70% consensus as important data to collect when monitoring children with GHD on rhGH treatment. Sixty-nine of the 219 items were deemed easy to collect. Combining the criteria of importance and ease of data collection, 63 met the criteria for the MDS. Several anomalies to the MDS rule were identified and highlighted for discussion, including whether the patients were involved in current or previous clinical trials, need for HbA1c monitoring, other past medical history, and adherence, enabling formulation of the final MDS recommendation of 43 items; 20 to be completed once, 14 every 6 months, and 9 every 12 months.

Conclusion

In summary, this exercise performed through the GloBE-Reg initiative provides a recommendation of the MDS requirement, collected through real-world data, for the monitoring of safety and effectiveness of rhGH in children with GHD, both for the current daily preparations and the newer long-acting GH.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Human Growth HormoneRecombinant ProteinsHumansChildFemaleMaleRegistriesGrowth DisordersChild, PreschoolAdolescentHormone Replacement Therapy

Stichwörter der Autor:innen

ChildrenEfficacyGrowth hormone therapyRegistrySafety

Substanzen

Human Growth HormoneRecombinant Proteins

Autor:innen und Institutionen

  • Developmental Endocrinology Research Group, University of Glasgow, Royal Hospital for Children, Glasgow, UK.
  • Office for Rare Conditions, University of Glasgow, Glasgow, UK.
  • Division of Endocrinology, Metabolism and Diabetes, First Department of Pediatrics, National and Kapodistrian University of Athens Medical School, "Aghia Sophia" Children's Hospital, Athens, Greece.
  • Department of Pediatrics, Asan Medical Center Children's Hospital, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Beijing Children's Hospital, The Capital Medical University, National Center for Children's Health, Beijing, China.
  • Department of Pediatrics, Pediatric Endocrinology Unit, Ain Shams University, Cairo, Egypt.

Zitieren

APA

Chen, S. C., Bryce, J., Chen, M., Charmandari, E., Choi, J. H., Dou, X., Gong, C., Hamza, R., Harvey, J., Hoffman, A. R., Horikawa, R., Johannson, G., Jorge, A. A. L., Miller, B. S., Roehrich, S., Sävendahl, L., Tseretopoulou, X., Vitali, D., Wajnrajch, M., & Ahmed, S. F. (2024). Development of a Minimum Dataset for the Monitoring of Recombinant Human Growth Hormone Therapy in Children with Growth Hormone Deficiency: A GloBE-Reg Initiative. Hormone Research in Paediatrics. https://doi.org/10.1159/000533763

Vancouver

Chen SC, Bryce J, Chen M, Charmandari E, Choi JH, Dou X, et al. Development of a Minimum Dataset for the Monitoring of Recombinant Human Growth Hormone Therapy in Children with Growth Hormone Deficiency: A GloBE-Reg Initiative. Hormone Research in Paediatrics. 2024. doi:10.1159/000533763

BibTeX
@article{Chen2024,
  author = {Chen, Suet Ching and Bryce, Jillian and Chen, Minglu and Charmandari, Evangelia and Choi, Jin-Ho and Dou, Xinyu and Gong, Chunxiu and Hamza, Rasha and Harvey, Jamie and Hoffman, Andrew R and Horikawa, Reiko and Johannson, Gudmundur and Jorge, Alexander Augusto de Lima and Miller, Bradley S and Roehrich, Sebastian and Sävendahl, Lars and Tseretopoulou, Xanthippi and Vitali, Diana and Wajnrajch, Michael and Ahmed, S Faisal},
  title = {Development of a Minimum Dataset for the Monitoring of Recombinant Human Growth Hormone Therapy in Children with Growth Hormone Deficiency: A GloBE-Reg Initiative},
  journal = {Hormone Research in Paediatrics},
  year = {2024},
  doi = {10.1159/000533763}
}
Kostenlos starten →